Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus

International Journal of Gynecological Cancer

Volumn 18, Issue 6, 2008, Pages 1200-1201

  Hoskins, P J ^a   Le, N ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Tumor markers; Uterine MMMT

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MIXED MULLERIAN TUMOR; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR BIOPSY; UTERUS CARCINOMA;

CARCINOSARCOMA; FEMALE; HUMANS; MIXED TUMOR, MULLERIAN; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 55949136915     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01187.x     Document Type: Article

References (12)

1. Surveillance, epidemiology and end results program: incidence and mortality data 1973-1977. Natl Cancer Inst Mongr 1981 57 : 1 1082.
2. Nordal R, Thoresen S. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer 1997 33 : 907 11.
3. Olah KS, Ger H, Blunt S et al. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 1991 27 : 1095 9.
4. McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 2002 12 : 687 90.
5. Cherchi P, Dessole S, Ruiu GA et al. The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma. Eur J Gynae Oncol 1999 20 : 315 7.
6. Koper NP, Massuger LF, Thomas CM et al. Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy. Anticancer Res 1998 18 : 1897 902.
7. Scambia G, Gadducci A, Panici PB et al. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma. Gynecol Oncol 1994 54 : 292 7.
8. Takeshima N, Shimizu Y, Umezawa S et al. Combined assay of serum levels of CA 125 and CA 19-9 in endometrial carcinoma. Gynecol Oncol 1994 54 : 321 6.
9. Kurihara T, Mizunuma H, Obara M et al. Determination of a normal level of serum CA 125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma. Gynecol Oncol 1998 69 : 193 6.
10. Duk JM, Aalders JG, Fleuren GJ et al. CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol 1986 155 : 1097 102.
11. Sood AK, Buller RE, Burger RA et al. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol 1997 90 : 441 7.
12. Nur S, Chuang L, Ramaswamy G. Immunohistochemical characterization of cancer antigen in uterine cancers. Int J Gynecol Cancer 2006 16 : 1903 10.